TABLE 3.

Association of retinal capillary plexus and ganglion cell complex with cognitive impairment in the logistic regression model.

Characteristics	OR (95%CI)	Adjusted OR (95%CI)
Superficial RCP, per 1 SD Decrease
Fovea	0.94 (0.83–1.06)	0.90 (0.78–1.04)
Parafovea	1.21 (1.06–1.37)	1.13 (0.98–1.29)
Temporal	1.17 (1.03–1.33)	1.10 (0.96–1.26)
Superior	1.22 (1.07–1.38)	1.14 (0.99–1.31)
Nasal	1.19 (1.05–1.35)	1.11 (0.96–1.27)
Inferior	1.19 (1.05–1.36)	1.13 (0.99–1.30)
Deep RCP, per 1 SD Decrease
Fovea	0.98 (0.86–1.12)	0.93 (0.80–1.07)
Parafovea	1.29 (1.14–1.47)	1.20 (1.03–1.39)
Temporal	1.29 (1.13–1.46)	1.18 (1.01–1.37)
Superior	1.28 (1.12–1.45)	1.21 (1.05–1.40)
Nasal	1.28 (1.13–1.46)	1.16 (1.00–1.35)
Inferior	1.26 (1.10–1.43)	1.17 (1.01–1.36)
FAZ, per 1 SD Decrease	1.11 (0.97–1.27)	1.14 (0.98–1.31)
PERIM, per 1 SD Decrease	1.10 (0.96–1.25)	1.13 (0.98–1.30)
AI, per 1 SD Increase	0.92 (0.81–1.05)	0.93 (0.81–1.06)
FD300 AD, per 1 SD Decrease	1.33 (1.17–1.52)	1.23 (1.07–1.41)
FD300 LD, per 1 SD Decrease	1.47 (1.29–1.68)	1.30 (1.13–1.49)
GCC, per 1 SD Decrease
Fovea	0.95 (0.84–1.09)	0.94 (0.82–1.09)
Parafovea	1.18 (1.04–1.34)	1.15 (1.00–1.32)
Temporal	1.15 (1.01–1.30)	1.13 (0.98–1.30)
Superior	1.21 (1.07–1.37)	1.16 (1.01–1.32)
Nasal	1.17 (1.03–1.33)	1.13 (0.99–1.30)
Inferior	1.17 (1.03–1.33)	1.14 (1.00–1.31)

Adjusted for age, sex, educational status, income, refraction, hypertension, diabetes, and dyslipidemia. OR, odds ratio; CI, confidence interval; RCP, retinal capillary plexus; FAZ, foveal avascular zone area; PERIM, foveal avascular zone perimeter; AI, acircularity index; FD300 AD, vessel area density within a 300 μm width ring surrounding the FAZ; FD300 LD, vessel length density within a 300 μm width ring surrounding the FAZ; GCC, ganglion cell complex.